定量177Lu-DOTATATE SPECT/CT可预测中肠神经内分泌瘤6个月PRRT形态反应:一个试点研究
Iness Megherbi1, Christopher Hoog2, Marine Perrier3
1Médecine Nucléaire, Institut Godinot, Reims, France.
EJNMMI research
|May 6, 2025
概括
使用SUVmax周期间变化的定量治疗后光学 (PTS) 可以预测接受177Lu-DOTATATE的小肠神经内分泌瘤 (siNET) 患者的治疗反应. 这种早期评估有助于预测6个月后的RECIST结果.
科学领域:
- 核医学就是核医学.
- 在瘤学瘤学.
- 放射性药理学 是一种放射性药理学.
背景情况:
- 用177Lu-DOTATATE进行受体放射性核素治疗 (PRRT) 是晚期小肠神经内分泌瘤 (siNET) 的关键治疗方法.
- 治疗反应通常在治疗后几个月使用RECIST标准进行评估.
- 由于缺乏量化,使用治疗后光学图 (PTS) 进行早期反应评估是有争议的.
研究的目的:
- 评估定量PTS的预测值,特别是177Lu-DOTATATE治疗的第一个 (C1) 和第二个 (C2) 周期之间的标准化摄入值 (SUVmax) 的变化.
- 为了将定量PTS发现与siNET患者的6个月RECIST反应相关联.
主要方法:
- 包括12名连续转移性siNET患者接受177Lu-DOTATATE治疗.
- 在C1和C2.2的PTS SPECT/CT上测量了最高吸收病变的SUVmax.
- 计算了∆SUVmax并使用线性回归分析了其与6个月RECIST的相关性.
主要成果:
- 在∆SUVmax和6个月RECIST百分比 (p < 0.001) 之间发现了强烈的相关性.
- 回归公式: 6个月的RECIST = -0.05 + 0.36 x ∆SUVmax.
- 代谢性瘤体积 (∆MTV) 的变化不能预测治疗反应.
结论:
- 定量PTS,特别是∆SUVmax,显著预测了与177Lu-DOTATATE治疗的siNET患者的6个月RECIST反应.
- 定量成像可以在C2的早期预测治疗反应.
- 需要在更大的患者队伍中进一步验证.
更多相关视频
08:55A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice
Published on: April 17, 2019
17.4K
09:49A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
Published on: April 24, 2020
9.6K
相关概念视频
Positron Emission Tomography
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
